Nitta Gelatin Inc.

The Group operates its collagen business globally, with the Company and its affiliated companies sharing responsibility for manufacturing and sales and working together to conduct business activities. The Group comprises the Company, 9 consolidated subsidiaries and 3 affiliated companies, and primarily handles products such as gelatin, collagen peptides, food ingredients and biomedical products. In the gelatin-related business, the Group manufactures and sells products across multiple regions, including Japan, North America, India, China and Vietnam. It is expanding sales of collagen peptides in Japan, North America, India and Asian markets, while working to improve profitability in the Japanese food ingredients market and strengthen manufacturing and sales at its Vietnam base. In the biomedical business, the Group is deepening its presence in the Chinese market and positioning the early commercialization of collagen microfibers as a growth driver. The long-term management vision was formulated in November 2025, establishing long-term targets for the fiscal year ending March 2033 and a medium-term plan extending through the fiscal year ending March 2027. For the fiscal year ending March 2033, the Group has set targets of approximately ¥80 billion in consolidated net sales and approximately ¥10 billion in operating income, and has established a vision of pursuing global markets with the aim of becoming Asia's No. 1 company by sales.